Caisse De Depot Et Placement Du Quebec Regeneron Pharmaceuticals, Inc. Transaction History

Caisse De Depot Et Placement Du Quebec

$40.9 Billion
Q1 2024

A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 228,001 shares of REGN stock, worth $240 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

228,001

Previous 260,166 12.36%

Holding current value

$240 Million

Previous $229 Million 3.96%

% of portfolio

0.54%

Previous 0.59%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $29 Million - $32 Million	-32,165 Reduced 12.36%	228,001 $219 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $86.9 Million - $98.8 Million	112,095 Added 75.7%	260,166 $229 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $22.3 Million - $27.2 Million	-32,187 Reduced 17.86%	148,071 $122 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $10.6 Million - $12.5 Million	15,106 Added 9.15%	180,258 $130 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $39.3 Million - $47.7 Million	57,736 Added 53.75%	165,152 $136 Million

Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $12.7 Million - $13.8 Million	-18,045 Reduced 14.38%	107,416 $77.5 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $8.98 Million - $11.3 Million	15,648 Added 14.25%	125,461 $86.4 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $29.5 Million - $39.8 Million	-53,850 Reduced 32.9%	109,813 $64.9 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $12.4 Million - $14.6 Million	-20,854 Reduced 11.3%	163,663 $114 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $33.7 Million - $41.6 Million	62,064 Added 50.68%	184,517 $117 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $47.5 Million - $56.4 Million	82,788 Added 208.72%	122,453 $74.1 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $15.3 Million - $18.1 Million	32,436 Added 448.69%	39,665 $22.2 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $138,933 - $170,490	-311 Reduced 4.12%	7,229 $3.42 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $1.53 Million - $1.95 Million	-3,209 Reduced 29.85%	7,540 $3.64 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $381,325 - $460,747	-700 Reduced 6.11%	10,749 $6.02 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $2.02 Million - $2.64 Million	-4,100 Reduced 26.37%	11,449 $7.14 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $1.45 Million - $2.13 Million	4,300 Added 38.23%	15,549 $7.59 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $27,413 - $37,651	100 Added 0.9%	11,249 $4.22 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $82,038 - $95,517	300 Added 2.77%	11,149 $3.09 Million
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $239,680 - $331,856	800 Added 7.96%	10,849 $3.4 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $483,704 - $571,441	1,300 Added 14.86%	10,049 $4.13 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $1.54 Million - $1.85 Million	4,600 Added 110.87%	8,749 $3.27 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $140,456 - $163,404	-400 Reduced 8.79%	4,149 $1.68 Million
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $1.45 Million - $1.76 Million	-5,100 Reduced 52.86%	4,549 $1.57 Million
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $473,730 - $590,670	1,500 Added 18.41%	9,649 $3.32 Million
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $179,315 - $234,975	-500 Reduced 5.78%	8,149 $3.06 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $3.73 Million - $4.36 Million	8,649	8,649 $3.88 Million

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.

Account

Caisse De Depot Et Placement Du Quebec Regeneron Pharmaceuticals, Inc. Transaction History